Located in Québec City, Canada, GenePOC Inc. develops, produces and commercialises easy-to-use molecular tests (GenePOC PIEs), to improve the diagnosis of infectious diseases at Point-of-Care. The GenePOC PIEs are single-use disposables to be used with the portable revogene instrument. Based on a unique microfluidic technology; extraction, real-time PCR and detection are integrated allowing the early detection of infectious diseases in less 70 minutes.
Business Needs: Investor
Countries of Interest: Belgium, Canada, Chile, China, Costa Rica, Finland, France, Greece, Honduras, Hong Kong, Hungary, Iceland, Ireland, Israel, Italy, Japan, Liechtenstein, Luxembourg, Monaco, Morocco, Netherlands, Niger, Peru, Portugal, Qatar, Spain, Sweden, Ukraine, United Arab Emirates, United Kingdom, United States